NCT01001130View on ClinicalTrials.gov

Regulatory AVAMYS Nasal Spray PMS

CompletedOBSERVATIONAL

Enrollment

3,244

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Rhinitis, Allergic, Perennial and Seasonal

Interventions

DRUG

fluticasone furoate group

patients who are administered fluticasone furoate at least once

Trial Locations (1)

463-707

GSK Investigational Site, Seongnam-si Gyeonggi-do

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01001130 - Regulatory AVAMYS Nasal Spray PMS | Biotech Hunter | Biotech Hunter